Please assess the completion status of the following clinical trial:

Trial Title: Evaluation of Orientation and Visual Acuity of Four Toric Soft Contact Lenses When Head is Tilted at 90 Degrees

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: CROSSOVER
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: SINGLE
- Phase: None
- Number of Arms: 12.0

Eligibility Criteria:
Inclusion Criteria:~1. be at least 18 and less than or equal to 50 years of age~2. be able and willing to adhere to the instructions set forth in the protocol.~3. have a distance spherical component between -1.00 D and -6.00D with cylinder in the range of 0.75 D to 1.75D~4. Sign the STATEMENT OF INFORMED CONSENT.~5. Have normal, healthy eyes~Exclusion Criteria:~1. The presence of ocular or systemic disease or need for medication which might interfere with contact lens wear.~2. Pre-existing ocular disease precluding contact lens fitting.~3. Insufficient lacrimal secretions~4. Aphakia, keratoconus or a highly irregular cornea~5. Previous eye surgery involving the anterior segment~6. Current pregnancy or lactation (to the best of the subject's knowledge).~7. Use of concurrent ocular medication~8. Active participation in another clinical study at any time during this study.-

- Gender: ALL
- Minimum Age: 18 Years
- Maximum Age: 50 Years
- Healthy Volunteers: f

Study Arms:
- Group 1: lotrafilcon B/senofilcon A/balafilcon A/omafilcon A (Type: ACTIVE_COMPARATOR): One intervention was worn during each study period, which consisted of lens insertion, followed by a 15 minute settling period prior to measurement. All four periods were conducted in one day. Period 1: lotrafilcon B /period 2: senofilcon A / period 3: balafilcon A / period 4: omafilcon A
- Group 2 lotrafilcon B/omafilcon A/senofilcon A/balafilcon A (Type: ACTIVE_COMPARATOR): One intervention was worn during each study period, which consisted of lens insertion, followed by a 15 minute settling period prior to measurement. All four periods were conducted in one day. period 1: lotrafilcon B / period 2: omafilcon A / period 3: senofilcon A / period 4: balafilcon A
- Group 3 lotrafilcon B/balafilcon A/senofilcon A/omafilcon A (Type: ACTIVE_COMPARATOR): One intervention was worn during each study period, which consisted of lens insertion, followed by a 15 minute settling period prior to measurement. All four periods were conducted in one day. period 1: lotrafilcon B / period 2: balafilcon A / period 3: senofilcon A / period 4: omafilcon A
- Group 4 senofilcon A/lotrafilcon B/omafilcon A/balafilcon A (Type: ACTIVE_COMPARATOR): One intervention was worn during each study period, which consisted of lens insertion, followed by a 15 minute settling period prior to measurement. All four periods were conducted in one day. period 1: senofilcon A / period 2: lotrafilcon B / period 3: omafilcon A / period 4: balafilcon A
- Group 5 senofilcon A/omafilcon A/balafilcon A/lotrafilcon B (Type: ACTIVE_COMPARATOR): One intervention was worn during each study period, which consisted of lens insertion, followed by a 15 minute settling period prior to measurement. All four periods were conducted in one day. period 1: senofilcon A / period 2: omafilcon A / period 3: balafilcon A / period 4: lotrafilcon B
- Group 6 senofilcon A/balafilcon A/lotrafilcon B/omafilcon A (Type: ACTIVE_COMPARATOR): One intervention was worn during each study period, which consisted of lens insertion, followed by a 15 minute settling period prior to measurement. All four periods were conducted in one day. period 1: senofilcon A / period 2: balafilcon A / period 3: lotrafilcon B / period 4: omafilcon A
- Group 7 omafilcon B/lotrafilcon B/senofilcon A/balafilcon A (Type: ACTIVE_COMPARATOR): One intervention was worn during each study period, which consisted of lens insertion, followed by a 15 minute settling period prior to measurement. All four periods were conducted in one day. period 1: omafilcon A / period 2: lotrafilcon B / period 3: senofilcon A / period 4: balafilcon A
- Group 8 balafilcon A/lotrafilcon B/senofilcon A/omafilcon A (Type: ACTIVE_COMPARATOR): One intervention was worn during each study period, which consisted of lens insertion, followed by a 15 minute settling period prior to measurement. All four periods were conducted in one day. period 1: balafilcon A / period 2: lotrafilcon B / period 3: senofilcon A / period 4: omafilcon A
- Group 9 balafilcon A/lotrafilcon B/omafilcon A/senofilcon A (Type: ACTIVE_COMPARATOR): One intervention was worn during each study period, which consisted of lens insertion, followed by a 15 minute settling period prior to measurement. All four periods were conducted in one day. period 1: balafilcon A / period 2: lotrafilcon B / period 3: omafilcon A / period 4: senofilcon A
- Group 10 balafilcon A/senofilcon A/lotrafilcon B/omafilcon A (Type: ACTIVE_COMPARATOR): One intervention was worn during each study period, which consisted of lens insertion, followed by a 15 minute settling period prior to measurement. All four periods were conducted in one day. period 1: balafilcon A / period 2: senofilcon A / period 3: lotrafilcon B / period 4: omafilcon A
- Group 11 balafilcon A/senofilcon A/omafilcon A//lotrafilcon B (Type: ACTIVE_COMPARATOR): One intervention was worn during each study period, which consisted of lens insertion, followed by a 15 minute settling period prior to measurement. All four periods were conducted in one day. period 1: balafilcon A / period 2: senofilcon A / period 3: omafilcon A / period 4: lotrafilcon B
- Group 12 balafilcon A/omafilcon A/lotrafilcon B/senofilcon A (Type: ACTIVE_COMPARATOR): One intervention was worn during each study period, which consisted of lens insertion, followed by a 15 minute settling period prior to measurement. All four periods were conducted in one day. period 1: balafilcon A / period 2: omafilcon A / period 3: lotrafilcon B / period 4: senofilcon A

Based on this trial design, predict the completion outcome and termination type (if applicable).